Comparison of methods for calculating rectal dose after (125)I prostate brachytherapy implants.
OBJECTIVE
To compare several different methods of calculating the rectal dose and examine how accurately they represent rectal dose surface area measurements and, also, their practicality for routine use.


METHODS
This study comprised 55 patients, randomly selected from 295 prostate brachytherapy patients implanted at the Vancouver Cancer Center between 1998 and 2000. All implants used a nonuniform loading of 0.33 mCi (NIST-99) 125I seeds and a prescribed dose of 144 Gy. Pelvic CT scans were obtained for each patient approximately 30 days after implantation. For the purposes of calculating the rectal dose, several structures were contoured on the CT images: (1) a 1-mm-thick anterior rectal wall, (2) the anterior half rectum, and (3) the whole rectum. Point doses were also obtained along the anterior rectal surface. The thin wall contour provided a surrogate for a dose-surface histogram (DSH) and was our reference standard rectal dose measurement. Alternate rectal dose measurements (volume, surface area, and length of rectum receiving a dose of interest [DOI] of > or =144 Gy and 216 Gy, as well as point dose measures) were calculated using several methods (VariSeed software) and compared with the surrogate DSH measure (SA(DOI)).


RESULTS
The best correlation with SA(144 Gy) was the dose volumes (whole or anterior half rectum) (R = 0.949). The length of rectum receiving > or =144 Gy also correlated well with SA(144 Gy) (R > or =0.898). Point dose measures, such as the average and maximal anterior dose, correlated poorly with SA(144 Gy) (R < or =0.649). The 216-Gy measurements supported these results. In addition, dose-volume measurements were the most practical (approximately 6 min/patient), with our surrogate DSH the least practical (approximately 20 min/patient).


CONCLUSIONS
Dose-volume measurements for the whole or anterior half rectum, because they were the most practical measures and best represented the DSH measurements, should be considered a standard method of reporting the rectal dose when calculating the DSH is not practical. Average or maximal anterior rectal doses are not reliable indicators of surface area dosimetry.
Hilts
Michelle
M
Department of Medical Physics, Vancouver Cancer Centre, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC V6R 2B6, Canada. mhilts@bccancer.bc.ca
Spadinger
Ingrid
I
Keyes
Mira
M
D000465:Algorithms; D001918:Brachytherapy; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D055585:Physical Phenomena; D010825:Physics; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D011829:Radiation Dosage; D011859:Radiography; D012007:Rectum / Q000000981:diagnostic imaging
D007457:Iodine Radioisotopes